avodart 0.5 mg
orifarm as - dutasterid - kapsel, myk - 0.5 mg
avodart 0.5 mg
orifarm as - dutasterid - kapsel, myk - 0.5 mg
zessly
sandoz gmbh - infliksimab - arthritis, psoriatic; psoriasis; crohn disease; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - immunsuppressive - behandling av revmatoid artritt, crohns sykdom, ulcerøs kolitt, bekhterevs sykdom, psoriasisartritt og psoriasis.
hulio
biosimilar collaborations ireland limited - adalimumab - hidradenitis suppurativa; psoriasis; uveitis; arthritis, rheumatoid; spondylitis, ankylosing; crohn disease; colitis, ulcerative; arthritis, psoriatic - immunosuppressants, tumor nekrose faktor alfa (tnf-α) - hemmere
vardenafil krka 20 mg
krka, d.d. novo mesto - vardenafilhydrokloridtrihydrat - tablett, filmdrasjert - 20 mg
vardenafil krka 10 mg
krka, d.d. novo mesto - vardenafilhydrokloridtrihydrat - tablett, filmdrasjert - 10 mg
levitra 20 mg
orifarm as - vardenafilhydroklorid - tablett, filmdrasjert - 20 mg
vardenafil aristo 10 mg
aristo pharma gmbh - vardenafilhydrokloridtrihydrat - tablett, filmdrasjert - 10 mg
vardenafil aristo 20 mg
aristo pharma gmbh - vardenafilhydrokloridtrihydrat - tablett, filmdrasjert - 20 mg
adcirca (previously tadalafil lilly)
eli lilly nederland b.v. - tadalafil - hypertensjon, pulmonal - urologika - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. effekt har blitt vist i idiopatisk pah (ipah) og i pah relatert til kollagenvaskulær sykdom. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.